BP726

(+)-cis-ジルチアゼム 塩酸塩

British Pharmacopoeia (BP) Reference Standard

• 別名: (2S,3S)-(+)-cis-3-アセトキシ-5-(2-ジメチルアミノエチル)-2,3-ジヒドロ-2-(4-メトキシフェニル)-1,5-ベンゾチアゼピン-4(5H)-オン 塩酸塩, CRD-401
• 実験式（ヒル表記法）: C₂₂H₂₆N₂O₄S · HCl
• CAS番号: 33286-22-5
• 分子量: 450.98
• Beilstein: 4228706
• MDL番号: MFCD00069252
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: diltiazem
• フォーム: powder
• シェルフライフ: limited shelf life, expiry date on the label
• メーカー／製品名: BP
• アプリケーション: pharmaceutical; pharmaceutical small molecule
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: Cl.COc1ccc(cc1)[C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
• InChI: 1S/C22H26N2O4S.ClH/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3;/h5-12,20-21H,13-14H2,1-4H3;1H/t20-,21+;/m1./s1
• InChI Key: HDRXZJPWHTXQRI-BHDTVMLSSA-N
• 遺伝子情報: human ... CACNA1C(775) , CACNA1D(776) , CACNA1F(778) , CACNA1S(779)

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Diltiazem hydrochloride BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Diltiazem Prolonged-release Tablets

Diltiazem Oral Suspension

包装

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302
• 注意書き: P264 - P270 - P301 + P312 + P330 - P501
• 危険有害性の分類: Acute Tox. 4 Oral
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable